enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding enVVeno Medical Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 24 | +1 |
| Shares | 1.92M | 1.93M | +14.6K (+0.8%) |
| Value | $5.90M | $10.4M | +$4.51M (+76.3%) |
New holders (4)
Institutions that held enVVeno Medical Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 17,753 | $95.0K | 0.00% |
| Fermata Advisors, LLC | 11,850 | $63.9K | 0.02% |
| Group One Trading, L.P. | 6,370 | $34.3K | 0.00% |
| JPMorgan Chase & Co | 11 | $59 | 0.00% |
Sold out (3)
Institutions that held enVVeno Medical Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Citadel Advisors LLC | 45,086 | $138.9K |
| Squarepoint Ops LLC | 13,291 | $40.9K |
| Renaissance Technologies LLC | 11,745 | $36.0K |